Patricia Yarberry Allen, M.D. is a Gynecologist, Director of the New York Menopause Center, Clinical Assistant Professor of Obstetrics and Gynecology at Weill Cornell Medical College, and Assistant Attending Obstetrician and Gynecologist at New York-Presbyterian Hospital. She is a board certified fellow of the American College of Obstetrics and Gynecology. Dr. Allen is also a member of the Faculty Advisory Board and the Women’s Health Director of The Weill Cornell Community Clinic (WCCC). Dr. Allen was the recipient of the 2014 American Medical Women’s Association Presidential Award.

This week, Denise Grady of the New York Times wrote about an important new study. It showed that radiation treatment used as part of the treatment for breast cancer significantly lowered cancer recurrence and death rates over a ten-to-fifteen year period. The results, published this week in the journal Lancet, are based on the evaluation of outcome for a large number of women followed over many years.

A report like this, based on an analysis of many studies involving thousands of women treated in many countries, provides a significant answer to an important question: Is radiation useful or harmful in the treatment of women with breast cancer? These findings will guide treatment protocols that will decrease breast cancer recurrence and death from this disease.

Take a look at Grady’s article and let us know what you think.

Join the conversation

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Diane Vacca October 24, 2011 at 2:23 pm

    I have a friend who’s just had a successful breast surgery. She will be having radiation for three weeks. In addition, her oncologist told her that taking
    estrogen blocker drugs known as Aromatase Inhibitors (ie Arimidex, Femara, Aromasin) gives one an additional 3% cure-rate. Do you have any information on that?